Quantification of neurodegeneration by measurement of brain-specific proteins

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 45-48

  Petzold, A ^a   Baker, D ^a   Pryce, G ^a   Keir, G ^a   Thompson, E J ^a   Giovannoni, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain specific proteins; EAE; ELISA; Ferritin; GFAP; NfHSM135; S100B; Surrogate marker

Indexed keywords

BIOLOGICAL MARKER; BRAIN PROTEIN; FERRITIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN S100B;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN LEVEL; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOSIS; HOMOGENATE; IMMUNOCYTOCHEMISTRY; MICROGLIA; MOUSE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SPINAL CORD; STAINING; TIME;

EID: 0037622169     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00092-4     Document Type: Article

References (10)

1. Baker D., O'Neill J., Gschmeissner S., Wilcox C., Butter C., Turk J. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28:1990;261-270.
2. Baker D., Pryce G., Croxford J.et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature. 404:2000;84-87.
3. Bjartmar C., Kidd G., Mork S., Rudick R., Trapp B. Neurological disability correlates with spinal cord axonal loss and reduced n-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48:2000;893-901.
4. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:2001;637-668.
5. Green A., Keir G., Thompson E. A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J. Immunol. Methods. 205:1997;35-41.
6. Keir G., Tasdemir N., Thompson E. Cerebrospinal-fluid ferritin in brain necrosis - evidence for local synthesis. Clin. Chim. Acta. 216:1993;153-166.
7. Newcombe J. Distribution of glial fibrillary acidic protein in gliosed human white matter. J. Neurochem. 47:1986;1713-1719.
8. Petzold A., Eikelenboom M., Gveric D., Keir G., Chapman M., Lazeron R., Cuzner M., Polman C., Uitdehaag B., Thompson E., Giovannoni G. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain. 125:2002;1462-1473.
9. Trapp B., Peterson J.et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
10. Wujek J., Bjartmar C., Richer E.et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 61:2002;23-32.